Peripheral airway obstruction in primary pulmonary hypertension

被引:102
作者
Meyer, FJ
Ewert, R
Hoeper, MM
Olschewski, H
Behr, J
Winkler, J
Wilkens, H
Breuer, C
Kübler, W
Borst, MM
机构
[1] Heidelberg Univ, Dept Internal Med 3, Heidelberg, Germany
[2] German Heart Ctr, Dept Cardiothorac Surg, Berlin, Germany
[3] Hannover Med Sch, Dept Pulmonary Med, Hannover, Germany
[4] Univ Giessen, Dept Internal Med 2, Giessen, Germany
[5] Univ Hosp, Dept Internal Med 1, Munich, Germany
[6] Univ Leipzig, Dept Internal Med, Leipzig, Germany
[7] Univ Saarland, Dept Pulmonary Med, Homburg, Germany
[8] Rhein Westfal TH Aachen, Univ Hosp, Det Internal Med, Aachen, Germany
关键词
D O I
10.1136/thorax.57.6.473
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: As there is controversy about changes in lung function in primary pulmonary hypertension (PPH), lung mechanics were assessed with a Focus on expiratory airflow in relation to pulmonary haemodynamics. Methods: A cross sectional study was performed in 64 controls and 171 patients with PPH (117 women) of mean (SD) age 45 (13) years, pulmonary artery pressure (PAPmean) 57 (15) mm Hg, and pulmonary vascular resistance 1371 (644) dyne.s/cm(5). Results: Mean (SD) total lung capacity was similar in patients with PPH and controls (98 (12)% predicted v 102 (17)% predicted, mean difference -4 (95% confidence interval (Cl) -7.89 to -0.11); residual volume (RV) was increased (118 (24)% predicted v 109 (27)% predicted, mean difference 9 (95% Cl 1.86 to 16.14); and vital capacity (VC) was decreased (91 (16)% predicted v 102 (10)% predicted, mean difference -11 (95% Cl 15.19 to -6.80). RV/TLC was increased (117 (27)% predicted v 97 (29)% predicted, mean difference 20 (95% Cl 12.3 to 27.8)) and correlated with PAPmean (r=0.31, p<0.001). In patients with PAPmean above the median of 56 mm Hg, RV/TLC was further increased (125 (32)% predicted v 111 (22)% predicted, mean difference -14 (95% Cl -22.2 to -5.8)). Expiratory flow-volume curves were reduced and curvilinear in patients with PPH. Conclusions: Peripheral airway obstruction is common in PPH and is more pronounced in severe disease. This may contribute to symptoms. Reversibility of bronchodilation and relation to exercise capacity need further evaluation.
引用
收藏
页码:473 / 476
页数:4
相关论文
共 32 条
[1]   STATISTICAL GUIDELINES FOR CONTRIBUTORS TO MEDICAL JOURNALS [J].
ALTMAN, DG ;
GORE, SM ;
GARDNER, MJ ;
POCOCK, SJ .
BRITISH MEDICAL JOURNAL, 1983, 286 (6376) :1489-1493
[2]   NITRIC-OXIDE IS THE ENDOGENOUS NEUROTRANSMITTER OF BRONCHODILATOR NERVES IN HUMANS [J].
BELVISI, MG ;
STRETTON, CD ;
YACOUB, M ;
BARNES, PJ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 210 (02) :221-222
[3]   PULMONARY-FUNCTION IN ADVANCED PULMONARY-HYPERTENSION [J].
BURKE, CM ;
GLANVILLE, AR ;
MORRIS, AJR ;
RUBIN, D ;
HARVEY, JA ;
THEODORE, J ;
ROBIN, ED .
THORAX, 1987, 42 (02) :131-135
[4]   IMPAIRMENT OF ENDOTHELIUM-DEPENDENT PULMONARY-ARTERY RELAXATION IN CHRONIC OBSTRUCTIVE LUNG-DISEASE [J].
DINHXUAN, AT ;
HIGENBOTTAM, TW ;
CLELLAND, CA ;
PEPKEZABA, J ;
CREMONA, G ;
BUTT, AY ;
LARGE, SR ;
WELLS, FC ;
WALLWORK, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (22) :1539-1547
[5]  
Ewert R, 2000, Z KARDIOL, V89, P987, DOI 10.1007/s003920070150
[6]   Role of endothelin-1 in lung disease [J].
Fagan, KA ;
McMurtry, IF ;
Rodman, DM .
RESPIRATORY RESEARCH, 2001, 2 (02) :90-101
[7]   PERIPHERAL AIRWAYS OBSTRUCTION IN IDIOPATHIC PULMONARY-ARTERY HYPERTENSION (PRIMARY) [J].
FERNANDEZBONETTI, P ;
LUPIHERRERA, E ;
MARTINEZGUERRA, ML ;
BARRIOS, R ;
SEOANE, M ;
SANDOVAL, J .
CHEST, 1983, 83 (05) :732-738
[8]  
GAZETOPOULOS N, 1974, BRIT HEART J, V36, P19
[9]   REDUCED EXPRESSION OF ENDOTHELIAL NITRIC-OXIDE SYNTHASE IN THE LUNGS OF PATIENTS WITH PULMONARY-HYPERTENSION [J].
GIAID, A ;
SALEH, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (04) :214-221
[10]   Determination of cardiac output by the Fick method, thermodilution, and acetylene rebreathing in pulmonary hypertension [J].
Hoeper, MM ;
Maier, R ;
Tongers, J ;
Niedermeyer, J ;
Hohlfeld, JM ;
Hamm, M ;
Fabel, H .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 160 (02) :535-541